Ron Finklestien
Bearish Report Predicts Chegg’s Demise
Bearish Report Predicts Chegg’s Demise
Chegg, Inc. CHGG shares have plummeted nearly 60% over the past year, and a recently released report by Edwin Dorsey’s “The Bear Cave” is ...
Gold Fields: Navigating a Rocky Road Ahead
Today’s piece centers on Gold Fields Limited (NYSE:NYSE:GFI), a stock that has undergone its fair share of ups and downs. We previously delved into ...
Challenges Hit NuScale Power as Layoffs Cut 40% of Workforce
Challenges Hit NuScale Power as Layoffs Cut 40% of Workforce
vchal/iStock via Getty Images NuScale Power (NYSE:SMR) saw a steep decline of 8.4% in Friday’s trading, marking its lowest close in six weeks. This ...
Exploring Ally and Synchrony Financial Stocks for Potential Upsides
Time to Buy Ally or Synchrony Financial Stock for Higher Highs?
As the financial sector gears up for the Q4 earnings season, multiple eyes are on big banks such as JP Morgan JPM and Bank ...
Two Gems in the Software & Services Industry for Savvy Investors
The Internet Software & Services Landscape and Investment Outlook The Internet-Software & Services industry shows signs of a mixed bag. Over the past year, ...
Mental Health Breakthrough: Compass Pathways and Greenbrook TMS Collaborate
Mental Health Breakthrough: Compass Pathways and Greenbrook TMS Collaborate
In a momentous stride towards innovation in mental health treatment, biotechnology company Compass Pathways plc (CMPS) and Greenbrook TMS Inc (GBNH) have cemented a ...
CG Oncology Pushes for $100M IPO Amid Ambiguous Terms, Symbolism
CG Oncology Pushes for $100M IPO Amid Ambiguous Terms, Symbolism
2d illustrations and photos CG Oncology (CGON) has opted to raise approximately $100M through an initial public offering, but the ambiguity surrounding the terms ...
Riding the Market Rollercoaster in 2024
Riding the Market Rollercoaster in 2024
Happy 2024, everyone! We hope everyone had a great holiday season. We thought we’d start the year with a quick recap of how markets ...
What’s The Scoop On Immunic Stock?
What’s The Scoop On Immunic Stock?
Immunic, Inc. IMUX shares are holding steady after the company announced a three-tranche private placement of up to $240 million. Breaking Down the Announcement: ...
Cannabis Revolutionizes Cancer Management, Confirms New Research
Cannabis Revolutionizes Cancer Management, Confirms New Research
A groundbreaking study recently published in the Journal of Cancer Survivorship has unveiled the widespread adoption of cannabis among individuals who have triumphed over ...
